Why GLP-1 users are turning to CGM

GLP-1 medications like Ozempic (semaglutide) and Wegovy work partly by slowing gastric emptying and improving insulin sensitivity — both of which directly affect your blood glucose patterns. But your prescriber typically only checks your HbA1c every 3 months. A CGM gives you continuous, real-time feedback on how well the medication is actually working for your metabolic health between appointments.

The core reason: GLP-1 medications reduce post-meal glucose spikes by slowing how quickly food leaves your stomach and by stimulating insulin release in response to meals. CGM makes this effect visible — you can watch your post-meal curve flatten as the medication takes effect, and track whether that improvement holds over time.

For weight loss users: many people on GLP-1s want to understand the metabolic changes happening alongside the weight loss. Are their fasting glucose levels improving? Are post-meal spikes reducing? Is their time in range improving? These are questions CGM answers directly.

For Type 2 diabetes users: if you're on Ozempic for blood sugar management, CGM provides the day-to-day data your prescriber uses only quarterly. You can see when your medication is most effective, how different meals affect your glucose on GLP-1s, and catch any episodes of low blood sugar before they become symptomatic.

Important distinction

If you use insulin alongside your GLP-1 medication, you need a prescription CGM (Dexcom G7 or FreeStyle Libre 3) — not an OTC device. OTC CGMs are not cleared for insulin dosing decisions. Talk to your prescriber.

What CGM reveals on GLP-1 medications

Flatter post-meal curves. One of the most visible effects of GLP-1 medications on CGM is the reduction in post-meal glucose peaks. Where you might have previously spiked to 170–190 mg/dL after a meal, GLP-1 medications often bring that peak down to 130–150 mg/dL as the medication slows gastric emptying and improves insulin response.

Lower fasting glucose. As GLP-1 medications improve insulin sensitivity over weeks and months, fasting glucose levels typically trend downward. CGM makes this trend visible — you can see your morning fasting glucose dropping from 105 mg/dL toward 90 mg/dL over your first few months on medication.

Reduced glucose variability. The large swings between high post-meal spikes and subsequent drops often reduce on GLP-1s. This stabilization shows up clearly on CGM as a smoother daily glucose curve — which correlates with fewer energy crashes, reduced hunger, and better mood stability.

Food response changes. Many GLP-1 users notice that foods that previously caused significant glucose spikes produce a blunted response on medication. CGM lets you observe which foods still drive spikes even on GLP-1s — useful for optimizing diet alongside medication.

Best CGM devices for GLP-1 users

Not on insulin — best OTC options:

Dexcom Stelo ($89–99/month) — best overall OTC CGM for GLP-1 users not on insulin. 15-day wear, excellent food logging, no prescription required. The app is built for non-clinical users and provides exactly the kind of lifestyle feedback GLP-1 users want. Read our full review →

Nutrisense ($179–299/month) — best if you want expert guidance alongside your data. A registered dietitian reviews your glucose data and helps you understand how your GLP-1 is affecting your metabolic health. Particularly valuable in the first months on medication. Read our full review →

On insulin — prescription required:

FreeStyle Libre 3 — best accuracy and value for GLP-1 users who also use insulin. Covered by most insurance when prescribed. Read our full review →

Do you need a prescription CGM on Ozempic?

If you use insulin: yes, you need a prescription CGM. OTC devices are not cleared for insulin dosing decisions. Your prescriber can write a prescription for the Dexcom G7 or FreeStyle Libre 3, and insurance is likely to cover it.

If you don't use insulin: no prescription needed. OTC CGMs like Dexcom Stelo and Abbott Lingo are available directly without a doctor visit for $89–99/month. These are specifically designed for adults without insulin-dependent diabetes — including people on GLP-1 medications for weight loss or blood sugar management.

Insurance coverage: OTC CGMs are generally not covered by insurance regardless of your GLP-1 medication status. If you have a Type 2 diabetes diagnosis and use insulin, prescription CGM may be covered — check with your insurer. See our full insurance guide →

Frequently asked questions

Can I use a CGM while on Ozempic?
Yes. CGM is compatible with GLP-1 medications including Ozempic and Wegovy. There are no interactions between CGM sensors and GLP-1 medications. If you don't use insulin, an OTC CGM like Dexcom Stelo requires no prescription.
Will Ozempic show up differently on CGM?
Yes — most users see flatter post-meal glucose curves, lower fasting glucose, and reduced overall glucose variability after starting GLP-1 medications. These changes typically become visible on CGM within the first 2–4 weeks of starting medication and continue improving over months.
How long should I wear a CGM on GLP-1s?
Most GLP-1 users benefit from wearing CGM during their first 1–3 months on medication — this is when the most significant metabolic changes are occurring and when the feedback is most valuable. After establishing a new baseline, periodic monitoring (one sensor per month or quarter) is sufficient for many users.
Does Ozempic cause low blood sugar (hypoglycemia)?
On its own, Ozempic rarely causes hypoglycemia in people without insulin-dependent diabetes — it only stimulates insulin release in response to elevated glucose. However, if you combine GLP-1 medications with insulin or sulfonylureas, hypoglycemia risk increases. CGM alerts for low glucose are particularly valuable in this situation.
GlucoseForge is reader-supported. When you purchase through links on this page, we may earn an affiliate commission at no extra cost to you.